Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Birmingham, AL
NPI: 1053726430Primary Employer
University of Alabama Health Services Foundation, PC.
uabmedicine.org
Looking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
AL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 130 | 344 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 44 | 44 |
Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry Study.
Authors: Kathleen Yost, Harshraj Leuva, John Chan, Inderjit Mehmi, Richard Schilsky, Eugene Ahn, Gordon Srkalovic, Ramya Thota
Publication Date: 2024-06-12
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Nivolumab, BIOLOGICAL: Ipilimumab, DRUG: Cabozantinib S-malate
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, DRUG: Atezolizumab, PROCEDURE: Computed Tomography, DRUG: Cobimetinib, PROCEDURE: Biopsy Procedure
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, OTHER: Pharmacological Study, BIOLOGICAL: Anetumab Ravtansine